Indian pharma should maintain facilities better: Kewal Handa
In coversation with NDTV Profit, pharma expert Kewal Handa shares his thoughts about the recent USA FDA 'warning letters' & 'import alert' for Indian companies and how Indian pharma should be more pro-active in maintaining facilities
